anxiety. Anxiety that is generalized and persistent but not restricted to, or even strongly predominating in, any particular environmental circumstances (i.e. it is
Conditions
Interventions
Intervention 1: Saffron capsule In this research, Goldaro Company produced 50 g of weighed saffron powder with powdered electric pulp and percolated with 70% alcohol percolation for 72 hours extractio
Treatment - Drugs
Placebo
Saffron capsule In this research, Goldaro Company produced 50 g of weighed saffron powder with powdered electric pulp and percolated with 70% alcohol percolation for 72 hours extraction. Then, it was
Placebo Capsule In order to remove the bias in the control group, the placebo containing 250 mg of lactose powder was prepared
Sponsors
Vice Chancellor for research of Shahid Beheshti University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
18 Years to 35 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: age between 18 to 35, first pregnancy; single pregnancy pregnancy; embryonic cephalic presentation; gestational age 40 to 41 weeks or more based on the first day of the last menstruation and ultrasonography of the first trimester; no uterine contraction; bishop score lower or equal to 4; healthy gestational sac; regular fetal heart rate; normal non-stress test; estimated embryo weighing 2500-4000; a low risk pregnancy (no known signs of internal and surgical diseases, or complications such as preeclampsia and Placental abruption and absence of known embryonic problems); pelvic stenosis; don’t receive any herbal remedy or medication such as misoprostol, prostaglandin, Oxytocin 36 hours before treatment; no sexual intercourse from 24 hours before and up to the end of the study. Exclusion criteria: oral consumption of saffron; uterine contraction; fetal heart rate abnormalities and absence of fetal movement, use of stimulants for uterine contractions during the study; such as castor oil; midwifery requiring emergency procedures, such as intense hemorrhage.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Anxiety. Timepoint: at the time of entering the study-- when admitted to the labor sector. Method of measurement: Spielberger anxiety questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactGiti Ozgoli
Shahid Beheshti University of Medical Sciences
Outcome results
None listed